📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE. (2018)

First Author: Josephs DH

Attributed to: Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/all.13455

PubMed Identifier: 29654623

Publication URI: http://europepmc.org/abstract/MED/29654623

Type: Journal Article/Review

Volume: 73

Parent Publication: Allergy

Issue: 12

ISSN: 0105-4538